The Prevacus Team

  • dr-v

    Jacob Vanlandingham, Ph.D.

    Dr. Vanlandingham holds a Ph.D. in Neuroscience from Florida State University, and a BS in Physical Therapy from Florida A & M University. He is a member of the Society for Neuroscience, American Society for Nutritional Sciences, National Neurotrauma Society, Faculty for Undergraduate Research in Neuroscience, and the International Association of Medical Science Educators.

    Read More »

  • michael-l

    Michael Lewandowski

    Mr. Lewandowski is an entrepreneur with over 37 years of pharmaceutical development experience working with pharmaceutical companies and clinical research organizations in developing small and large molecule drugs.

    Read More »

  • megan

    Megan Munyon

    Miss Deane brings over ten years’ experience in the hospitality industry, as well as management skills from a variety of business operations.

    Read More »

  • bio-joe_1

    Joseph Story

    Joseph Story- Clinical and Business Development Lead M.D., University of Alabama, Family Medicine Developed over $2B in healthcare revenue services Co-Founder of TriCare Rehabilitation Centers and Ultimate Settlements President of Andrews Research and Education Institute Vice President of Business Development at Baptist Health Care Chairman of The Dr. James Andrews Orthopedic and Sports Medicine Institute […]

    Read More »

  • jamesKellyBio

    James Kelly, M.D.

    Dr. Kelly is the former Director of the US National Intrepid Center of Excellence (NiCOE). Dr. Kelly a neurologist was the original Director of NiCOE which is the foremost treatment center for brain-injured warriors in the United States. Dr. Kelly is currently practicing in Colorado and a member of the medical school team at the […]

    Read More »

  • marc

    Marc Cantillon

    Dr. Cantillon is a pharmaceutical physician executive with over 16 years of broad experience across multiple critical functions.

    Read More »

  • deepa

    Deepa Deshpande

    Dr. Deshpande is providing guidance for the Regulatory pathway to get a drug approved by the FDA.

    Read More »

  • daniel

    Daniel Levy

    Dr. Levy’s role is to manage the synthetic process development of PRV-001 with the goal to optimize the process for yield and manufacturing cost.

    Read More »

  • scott

    Scott M. Wheelwright, Ph.D.

    Dr. Wheelwright is our lead consultant for CMC, including manufacturing and quality assurance.

    Read More »

Recent News